Loan & DebtJul 17, 2026, 08:08 AM
Glucotrack Completes Bridge Financing to Support Strategic Growth
AI Summary
Glucotrack, Inc., along with its operating business Lōkahi Therapeutics, announced the successful completion of a bridge financing. This funding is intended to support the company's strategic growth objectives, including the continued advancement of the combined Glucotrack–Lōkahi platform and anticipated capital markets activities. The financing follows the recent business combination between Glucotrack and Lōkahi, with E.F. Hutton & Co. advising on the deal and continuing to support future capital formation opportunities.
Key Highlights
- Glucotrack completed a bridge financing to support strategic growth objectives.
- The financing will advance the combined Glucotrack–Lōkahi platform and capital markets activities.
- This follows the strategic business combination between Glucotrack and Lōkahi announced on July 14, 2026.
- E.F. Hutton & Co. served as exclusive financial advisor and placement agent for the financing.
- The financing provides additional financial flexibility for strategic initiatives under evaluation.
- Lōkahi Therapeutics continues to advance its ai² Futures Lab program leveraging university relationships.
Price Impact
More from GCTK